Artificial Intelligence in Pharma Space

B.pharmacy

A subfield of computer science called artificial intelligence (AI) gives robots the ability to analyze complicated data and operate more productively. AI-focused research has grown significantly, and its application to healthcare services and research is developing at a faster rate. The advantages and difficulties of AI in medical and pharmaceutical industry are covered in detail in this paper. This article discussed in great detail the use of AI in medication discovery and pandemic or epidemic predictions. The most popular artificial intelligence (AI) technologies are deep learning and neural networks; prospective technologies for clinical trial design are Bayesian nonparametric models; wearable technology and natural language processing are employed for patient identification and clinical trial monitoring. In order to predict the outbreaks of COVID-19, Zika, Ebola, and seasonal influenza, deep learning and neural networks were utilized. The scientific community may see quick and affordable advances in pharmaceutical and healthcare research as well as better public services thanks to the development of AI technologies. The pharmaceutical sector is leading the way in the deployment of artificial intelligence (AI), utilizing state-of-the-art technologies to transform research and medication development procedures. The industry’s dedication to using AI for innovation and efficiency is demonstrated by strategic agreements and job possibilities, even in the face of a drop in patent filings. Beyond the pharmaceutical industry, artificial intelligence has an impact on many other businesses. This analysis highlights the several AI-based techniques used in pharmaceutical technology. However, the pharmaceutical industry’s ongoing exploration and investment in AI present great opportunities for improving patient care and drug development procedures.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.